Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics

• Cristiano Chaves,
• Rafael G. dos Santos,
• Rafael G. dos Santos,
• Serdar M. Dursun,
• Serdar M. Dursun,
• Massimo Tusconi,
• Mauro Giovanni Carta,
• Elisa Brietzke,
• Jaime E. C. Hallak,
• Jaime E. C. Hallak,
• Jaime E. C. Hallak

Affiliations

Cristiano Chaves

NeuroMood Lab, School of Medicine and Kingston Health Sciences Centre (KHSC), Department of Psychiatry, Queen’s University, Kingston, ON, Canada

Rafael G. dos Santos

Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil

Rafael G. dos Santos

National Institute for Translational Medicine (INCT-TM), CNPq, São Paulo, Brazil

Serdar M. Dursun

National Institute for Translational Medicine (INCT-TM), CNPq, São Paulo, Brazil

Serdar M. Dursun

Department of Psychiatry (Neurochemical Research Unit) and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada

Massimo Tusconi

University Hospital of Cagliari, Cagliari, Italy

Mauro Giovanni Carta

Department of Medical Sciences and Public Health, University of Cagliari, Cagliari, Italy

Elisa Brietzke

NeuroMood Lab, School of Medicine and Kingston Health Sciences Centre (KHSC), Department of Psychiatry, Queen’s University, Kingston, ON, Canada

Jaime E. C. Hallak

Department of Neuroscience and Behavior, Ribeirão Preto Medical School, University of São Paulo, São Paulo, Brazil

Jaime E. C. Hallak

National Institute for Translational Medicine (INCT-TM), CNPq, São Paulo, Brazil

Jaime E. C. Hallak

Department of Psychiatry (Neurochemical Research Unit) and Neuroscience and Mental Health Institute, University of Alberta, Edmonton, AB, Canada